A composite reference standard is needed for bedaquiline antimicrobial susceptibility testing for Mycobacterium tuberculosis complex

Eur Respir J. 2024 Jul 11;64(1):2400391. doi: 10.1183/13993003.00391-2024. Print 2024 Jul.

Abstract

A composite reference standard minimises false-susceptible AST results for bedaquiline https://bit.ly/3wAVvFm

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents* / pharmacology
  • Antitubercular Agents* / therapeutic use
  • Diarylquinolines* / pharmacology
  • Diarylquinolines* / therapeutic use
  • Humans
  • Microbial Sensitivity Tests*
  • Mycobacterium tuberculosis* / drug effects
  • Reference Standards*
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Multidrug-Resistant / microbiology

Substances

  • bedaquiline
  • Diarylquinolines
  • Antitubercular Agents